Literature DB >> 19073888

The NatA acetyltransferase couples Sup35 prion complexes to the [PSI+] phenotype.

John A Pezza1, Sara X Langseth, Rochele Raupp Yamamoto, Stephen M Doris, Samuel P Ulin, Arthur R Salomon, Tricia R Serio.   

Abstract

Protein-only (prion) epigenetic elements confer unique phenotypes by adopting alternate conformations that specify new traits. Given the conformational flexibility of prion proteins, protein-only inheritance requires efficient self-replication of the underlying conformation. To explore the cellular regulation of conformational self-replication and its phenotypic effects, we analyzed genetic interactions between [PSI(+)], a prion form of the S. cerevisiae Sup35 protein (Sup35([PSI+])), and the three N(alpha)-acetyltransferases, NatA, NatB, and NatC, which collectively modify approximately 50% of yeast proteins. Although prion propagation proceeds normally in the absence of NatB or NatC, the [PSI(+)] phenotype is reversed in strains lacking NatA. Despite this change in phenotype, [PSI(+)] NatA mutants continue to propagate heritable Sup35([PSI+]). This uncoupling of protein state and phenotype does not arise through a decrease in the number or activity of prion templates (propagons) or through an increase in soluble Sup35. Rather, NatA null strains are specifically impaired in establishing the translation termination defect that normally accompanies Sup35 incorporation into prion complexes. The NatA effect cannot be explained by the modification of known components of the [PSI(+)] prion cycle including Sup35; thus, novel acetylated cellular factors must act to establish and maintain the tight link between Sup35([PSI+]) complexes and their phenotypic effects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19073888      PMCID: PMC2633373          DOI: 10.1091/mbc.e08-04-0436

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  85 in total

1.  Evidence for a protein mutator in yeast: role of the Hsp70-related chaperone ssb in formation, stability, and toxicity of the [PSI] prion.

Authors:  Y O Chernoff; G P Newnam; J Kumar; K Allen; A D Zink
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  Identification and specificities of N-terminal acetyltransferases from Saccharomyces cerevisiae.

Authors:  B Polevoda; J Norbeck; H Takakura; A Blomberg; F Sherman
Journal:  EMBO J       Date:  1999-11-01       Impact factor: 11.598

3.  New yeast genes important for chromosome integrity and segregation identified by dosage effects on genome stability.

Authors:  I I Ouspenski; S J Elledge; B R Brinkley
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

4.  Interaction of the GATA factor Gln3p with the nitrogen regulator Ure2p in Saccharomyces cerevisiae.

Authors:  D Blinder; P W Coschigano; B Magasanik
Journal:  J Bacteriol       Date:  1996-08       Impact factor: 3.490

5.  Genetic study of interactions between the cytoskeletal assembly protein sla1 and prion-forming domain of the release factor Sup35 (eRF3) in Saccharomyces cerevisiae.

Authors:  P A Bailleul; G P Newnam; J N Steenbergen; Y O Chernoff
Journal:  Genetics       Date:  1999-09       Impact factor: 4.562

6.  Increased expression of Hsp40 chaperones, transcriptional factors, and ribosomal protein Rpp0 can cure yeast prions.

Authors:  Dmitry S Kryndushkin; Vladimir N Smirnov; Michael D Ter-Avanesyan; Vitaly V Kushnirov
Journal:  J Biol Chem       Date:  2002-03-28       Impact factor: 5.157

7.  Interaction between yeast Sup45p (eRF1) and Sup35p (eRF3) polypeptide chain release factors: implications for prion-dependent regulation.

Authors:  S V Paushkin; V V Kushnirov; V N Smirnov; M D Ter-Avanesyan
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

8.  The ARD1 gene of yeast functions in the switch between the mitotic cell cycle and alternative developmental pathways.

Authors:  M Whiteway; J W Szostak
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

9.  Protein-only transmission of three yeast prion strains.

Authors:  Chih-Yen King; Ruben Diaz-Avalos
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

10.  Mechanism of inhibition of Psi+ prion determinant propagation by a mutation of the N-terminus of the yeast Sup35 protein.

Authors:  N V Kochneva-Pervukhova; S V Paushkin; V V Kushnirov; B S Cox; M F Tuite; M D Ter-Avanesyan
Journal:  EMBO J       Date:  1998-10-01       Impact factor: 11.598

View more
  11 in total

1.  A size threshold limits prion transmission and establishes phenotypic diversity.

Authors:  Aaron Derdowski; Suzanne S Sindi; Courtney L Klaips; Susanne DiSalvo; Tricia R Serio
Journal:  Science       Date:  2010-10-29       Impact factor: 47.728

Review 2.  Defining the limits: Protein aggregation and toxicity in vivo.

Authors:  William M Holmes; Courtney L Klaips; Tricia R Serio
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-04-28       Impact factor: 8.250

Review 3.  The biological functions of Naa10 - From amino-terminal acetylation to human disease.

Authors:  Max J Dörfel; Gholson J Lyon
Journal:  Gene       Date:  2015-05-16       Impact factor: 3.688

4.  Dominant prion mutants induce curing through pathways that promote chaperone-mediated disaggregation.

Authors:  Susanne DiSalvo; Aaron Derdowski; John A Pezza; Tricia R Serio
Journal:  Nat Struct Mol Biol       Date:  2011-03-20       Impact factor: 15.369

5.  Loss of amino-terminal acetylation suppresses a prion phenotype by modulating global protein folding.

Authors:  William M Holmes; Brian K Mannakee; Ryan N Gutenkunst; Tricia R Serio
Journal:  Nat Commun       Date:  2014-07-15       Impact factor: 14.919

6.  Amyloid-associated activity contributes to the severity and toxicity of a prion phenotype.

Authors:  John A Pezza; Janice Villali; Suzanne S Sindi; Tricia R Serio
Journal:  Nat Commun       Date:  2014-07-15       Impact factor: 14.919

7.  Distinct Prion Domain Sequences Ensure Efficient Amyloid Propagation by Promoting Chaperone Binding or Processing In Vivo.

Authors:  Christine R Langlois; Fen Pei; Suzanne S Sindi; Tricia R Serio
Journal:  PLoS Genet       Date:  2016-11-04       Impact factor: 5.917

8.  A dominant-negative mutant inhibits multiple prion variants through a common mechanism.

Authors:  Fen Pei; Susanne DiSalvo; Suzanne S Sindi; Tricia R Serio
Journal:  PLoS Genet       Date:  2017-10-30       Impact factor: 5.917

9.  Spatial quality control bypasses cell-based limitations on proteostasis to promote prion curing.

Authors:  Courtney L Klaips; Megan L Hochstrasser; Christine R Langlois; Tricia R Serio
Journal:  Elife       Date:  2014-12-09       Impact factor: 8.140

Review 10.  N-Terminal Acetylation-Targeted N-End Rule Proteolytic System: The Ac/N-End Rule Pathway.

Authors:  Kang-Eun Lee; Ji-Eun Heo; Jeong-Mok Kim; Cheol-Sang Hwang
Journal:  Mol Cells       Date:  2016-02-16       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.